First Quadrant’s AtriCure ATRC Stock Holding History

First Quadrant’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-4,326	Closed	-$132K	–	710
2018 Q4	$132K	Buy	+4,326	New	+$135K	0.01%	605

Other funds holding ATRC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

First Quadrant's ATRC Position: Q1 2019 in Review

First Quadrant sold out of AtriCure (ATRC) in Q1 2019, closing a stake of 4,326 shares — an estimated $132K sold.

First Quadrant first reported a position in ATRC in Q4 2018 and held it in 1 quarter. The position peaked at $132K in Q4 2018. 160 funds tracked by Wall St. Rank hold ATRC as of Q1 2019.

First Quadrant reported no remaining AtriCure position as of Q1 2019 after selling out during the quarter.
First Quadrant sold 4,326 AtriCure shares in Q1 2019, an estimated $132K.
First Quadrant first reported a position in AtriCure in Q4 2018 and held it in 1 quarter.
First Quadrant's AtriCure position peaked at $132K in Q4 2018.
160 funds tracked by Wall St. Rank held AtriCure as of Q1 2019.

Based on First Quadrant's 13F filing for Q1 2019, filed 24 Apr 2019.